Company Profile
LogicBio Therapeutics
Company Overview
At LogicBio, our mission is to develop medicines to durably treat rare diseases in patients with significant unmet medical needs using, GeneRide™, our proprietary technology platform. GeneRide™ enables the site-specific integration of a therapeutic transgene in a nuclease-free and promoterless approach by relying on the native process of homologous recombination to drive lifelong expression. Headquartered in Cambridge, Mass., we are committed to developing medicines that will transform the lives of pediatric patients and their families.